A detailed history of Israel Englander (Millennium Management LLC) transactions in Selecta Biosciences Inc stock. As of the latest transaction made, Millennium Management LLC holds 994,632 shares of SELB stock, worth $835,490. This represents 0.0% of its overall portfolio holdings.

Number of Shares
994,632
Previous 215,775 360.96%
Holding current value
$835,490
Previous $148,000 464.19%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.62 - $0.85 $482,891 - $662,028
778,857 Added 360.96%
994,632 $835,000
Q4 2023

Feb 14, 2024

SELL
$0.67 - $1.35 $683,747 - $1.38 Million
-1,020,518 Reduced 82.55%
215,775 $148,000
Q2 2023

Aug 14, 2023

SELL
$1.04 - $1.4 $675,554 - $909,400
-649,572 Reduced 34.44%
1,236,293 $1.38 Million
Q1 2023

May 15, 2023

BUY
$1.15 - $1.89 $267,893 - $440,277
232,951 Added 14.09%
1,885,865 $2.62 Million
Q4 2022

Feb 14, 2023

SELL
$0.96 - $1.6 $3.07 Million - $5.11 Million
-3,192,838 Reduced 65.89%
1,652,914 $1.87 Million
Q3 2022

Nov 14, 2022

BUY
$1.33 - $2.6 $4.71 Million - $9.21 Million
3,542,802 Added 271.91%
4,845,752 $7.95 Million
Q2 2022

Aug 15, 2022

SELL
$0.67 - $1.4 $358,545 - $749,198
-535,142 Reduced 29.11%
1,302,950 $1.71 Million
Q1 2022

May 16, 2022

BUY
$1.23 - $3.31 $968,385 - $2.61 Million
787,305 Added 74.93%
1,838,092 $2.26 Million
Q4 2021

Feb 14, 2022

BUY
$2.89 - $4.43 $1.98 Million - $3.04 Million
686,497 Added 188.45%
1,050,787 $3.43 Million
Q3 2021

Nov 15, 2021

SELL
$3.36 - $4.62 $3.03 Million - $4.16 Million
-900,650 Reduced 71.2%
364,290 $1.52 Million
Q2 2021

Aug 16, 2021

BUY
$2.82 - $5.01 $404,994 - $719,511
143,615 Added 12.81%
1,264,940 $5.29 Million
Q1 2021

May 17, 2021

BUY
$2.92 - $5.07 $1.42 Million - $2.46 Million
485,292 Added 76.3%
1,121,325 $5.07 Million
Q4 2020

Feb 16, 2021

SELL
$1.64 - $3.42 $1.58 Million - $3.29 Million
-963,017 Reduced 60.22%
636,033 $1.93 Million
Q3 2020

Nov 16, 2020

SELL
$2.18 - $2.84 $305,548 - $398,054
-140,160 Reduced 8.06%
1,599,050 $3.97 Million
Q2 2020

Aug 14, 2020

SELL
$1.83 - $4.06 $1.53 Million - $3.39 Million
-835,835 Reduced 32.46%
1,739,210 $4.94 Million
Q1 2020

May 14, 2020

BUY
$1.5 - $4.52 $1.77 Million - $5.34 Million
1,181,765 Added 84.82%
2,575,045 $6.21 Million
Q4 2019

Feb 14, 2020

BUY
$1.32 - $2.47 $1.49 Million - $2.79 Million
1,130,255 Added 429.71%
1,393,280 $3.32 Million
Q3 2019

Nov 14, 2019

SELL
$1.6 - $2.08 $231,339 - $300,740
-144,587 Reduced 35.47%
263,025 $460,000
Q2 2019

Aug 15, 2019

BUY
$1.79 - $3.05 $729,625 - $1.24 Million
407,612 New
407,612 $730,000
Q1 2019

May 14, 2019

SELL
$1.47 - $3.06 $15,439 - $32,139
-10,503 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$2.66 - $15.93 $317,497 - $1.9 Million
-119,360 Reduced 91.91%
10,503 $28,000
Q3 2018

Nov 14, 2018

BUY
$12.07 - $16.0 $125,479 - $166,336
10,396 Added 8.7%
129,863 $2.02 Million
Q2 2018

Aug 14, 2018

BUY
$9.36 - $13.25 $1.12 Million - $1.58 Million
119,467 New
119,467 $1.58 Million
Q1 2018

May 15, 2018

SELL
$8.49 - $11.82 $2.42 Million - $3.37 Million
-285,266 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$8.97 - $23.38 $1.99 Million - $5.19 Million
222,152 Added 351.99%
285,266 $2.8 Million
Q3 2017

Nov 14, 2017

BUY
$15.22 - $20.03 $960,595 - $1.26 Million
63,114
63,114 $1.15 Million

Others Institutions Holding SELB

About SELECTA BIOSCIENCES INC


  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.